Who is sponsoring NCT02704780?

NCT02704780 is sponsored by Hawler Medical University.

What condition does NCT02704780 study?

NCT02704780 studies Postpartum Haemorrhage, Retained Placenta.

What is the status of NCT02704780?

NCT02704780 is currently COMPLETED.

Last reviewed 2019-02-21 · How we verify

Umbilical Vein Injection of 800µg Misoprostol Versus 400 µg Misoprostol in the Treatment of Retained Placenta: A Multicenter, Randomized Double Blind Controlled Trial

NCT02704780 Phase 2 COMPLETED

This study evaluates intra umbilical vein injection of 800 µg versus 400 µg misoprostol for the treatment of retained placenta to reduce the need of manual removal of placenta under general anaesthesia

Details

Lead sponsor	Hawler Medical University
Phase	Phase 2
Status	COMPLETED
Enrolment	509
Start date	2016-03
Completion	2019-02-14

Conditions

Postpartum Haemorrhage
Retained Placenta

Interventions

Misoprostol

Primary outcomes

Delivery of placenta after injection of of 400 Microgram intraumbilical misoprostol versus 800 microgram of misoprostol — up to 30 minutes after intraumbilical injection
complete delivery of placenta after injection of intraumbilical misoprostol

Countries

Iraq